{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T17:16:53Z","timestamp":1793639813501,"version":"4.5.1"},"reference-count":111,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,3,3]],"date-time":"2020-03-03T00:00:00Z","timestamp":1583193600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001003","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001003","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006591","name":"FibroGen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006591","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002429","name":"Amgen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015340","name":"Bayer Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015340","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004324","name":"Astellas Pharma US","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004324","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019120","name":"Otsuka America","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019120","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006484","name":"Vifor Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006484","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["kidneymedicinejournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney Medicine"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.xkme.2020.01.006","type":"journal-article","created":{"date-parts":[[2020,3,27]],"date-time":"2020-03-27T11:21:12Z","timestamp":1585308072000},"page":"341-353","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"title":["Iron Administration, Infection, and Anemia Management in CKD: Untangling the Effects of Intravenous Iron Therapy on Immunity and Infection Risk"],"prefix":"10.1016","volume":"2","author":[{"given":"Tomas","family":"Ganz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George R.","family":"Aronoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo A.J.M.","family":"Gaillard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence T.","family":"Goodnough","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iain C.","family":"Macdougall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gert","family":"Mayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gra\u00e7a","family":"Porto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang C.","family":"Winkelmayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay B.","family":"Wish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.xkme.2020.01.006_bib1","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1159\/000486968","article-title":"Positive iron balance in chronic kidney disease: how much is too much and how to tell?","volume":"47","author":"Wish","year":"2018","journal-title":"Am J Nephrol"},{"issue":"1","key":"10.1016\/j.xkme.2020.01.006_bib3","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2215\/CJN.01670408","article-title":"Iron indices in chronic kidney disease in the National Health and Nutritional Examination Survey 1988-2004","volume":"4","author":"Fishbane","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.xkme.2020.01.006_bib4","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s12882-018-0861-1","article-title":"Prevalence, treatment patterns, and healthcare resource utilization in Medicare and commercially insured non-dialysis-dependent chronic kidney disease patients with and without anemia in the United States","volume":"19","author":"St Peter","year":"2018","journal-title":"BMC Nephrol"},{"issue":"1","key":"10.1016\/j.xkme.2020.01.006_bib5","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.kint.2015.10.002","article-title":"Iron management in chronic kidney disease: conclusions from a \u201cKidney Disease: Improving Global Outcomes\u201d (KDIGO) Controversies Conference","volume":"89","author":"Macdougall","year":"2016","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.xkme.2020.01.006_bib6","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1053\/j.ackd.2019.01.004","article-title":"Immune dysfunction and risk of infection in chronic kidney disease","volume":"26","author":"Syed-Ahmed","year":"2019","journal-title":"Adv Chronic Kidney Dis"},{"issue":"5","key":"10.1016\/j.xkme.2020.01.006_bib7","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.2215\/CJN.01290308","article-title":"Epidemiology of acute infections among patients with chronic kidney disease","volume":"3","author":"Dalrymple","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3 suppl 1","key":"10.1016\/j.xkme.2020.01.006_bib8","article-title":"US Renal Data System 2018 Annual Data Report: epidemiology of kidney disease in the United States","volume":"73","author":"Saran","year":"2019","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"10.1016\/j.xkme.2020.01.006_bib9","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1111\/j.1523-1755.2000.00337.x","article-title":"Mortality caused by sepsis in patients with end-stage renal disease compared with the general population","volume":"58","author":"Sarnak","year":"2000","journal-title":"Kidney Int"},{"issue":"3","key":"10.1016\/j.xkme.2020.01.006_bib10","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1053\/j.ajkd.2011.07.012","article-title":"The risk of infection-related hospitalization with decreased kidney function","volume":"59","author":"Dalrymple","year":"2012","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"10.1016\/j.xkme.2020.01.006_bib11","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1053\/j.ajkd.2016.09.018","article-title":"CKD and risk for hospitalization with infection: the Atherosclerosis Risk in Communities (ARIC) study","volume":"69","author":"Ishigami","year":"2017","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"10.1016\/j.xkme.2020.01.006_bib12","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1053\/j.ackd.2006.04.004","article-title":"Infectious complications in chronic kidney disease","volume":"13","author":"Naqvi","year":"2006","journal-title":"Adv Chronic Kidney Dis"},{"issue":"22","key":"10.1016\/j.xkme.2020.01.006_bib13","article-title":"Inpatient and outpatient infection as a trigger of cardiovascular disease: the ARIC study","volume":"7","author":"Cowan","year":"2018","journal-title":"J\u00a0Am Heart Assoc"},{"issue":"4","key":"10.1016\/j.xkme.2020.01.006_bib14","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.kint.2016.07.013","article-title":"Infection in advanced chronic kidney disease leads to increased risk of cardiovascular events, end-stage kidney disease and mortality","volume":"90","author":"Cheikh Hassan","year":"2016","journal-title":"Kidney Int"},{"key":"10.1016\/j.xkme.2020.01.006_bib15","doi-asserted-by":"crossref","unstructured":"Macdougall IC, Bhandari S, White C, et al. Intravenous iron dosing and infection risk in patients on hemodialysis: a prespecified secondary analysis of the PIVOTAL trial [published online ahead of print April 6, 2020]. J Am Soc Nephrol. https:\/\/doi.org\/10.1681\/ASN.2019090972.","DOI":"10.1681\/ASN.2019090972"},{"issue":"5","key":"10.1016\/j.xkme.2020.01.006_bib16","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.2215\/CJN.00950208","article-title":"Aspects of immune dysfunction in end-stage renal disease","volume":"3","author":"Kato","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"issue":"6","key":"10.1016\/j.xkme.2020.01.006_bib17","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1681\/ASN.2018010068","article-title":"Circulating bacterial fragments as cardiovascular risk factors in CKD","volume":"29","author":"Szeto","year":"2018","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"10","key":"10.1016\/j.xkme.2020.01.006_bib18","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1038\/nri3523","article-title":"The immune system and kidney disease: basic concepts and clinical implications","volume":"13","author":"Kurts","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.xkme.2020.01.006_bib19","doi-asserted-by":"crossref","DOI":"10.1177\/2054358119839080","article-title":"Infectious disease risk in dialysis patients: a transdisciplinary approach","volume":"6","author":"Lamarche","year":"2019","journal-title":"Can J Kidney Health Dis"},{"key":"10.1016\/j.xkme.2020.01.006_bib20","doi-asserted-by":"crossref","first-page":"5765417","DOI":"10.1155\/2017\/5765417","article-title":"Intestinal barrier disturbances in haemodialysis patients: mechanisms, consequences, and therapeutic options","volume":"2017","author":"March","year":"2017","journal-title":"Biomed Res Int"},{"issue":"673","key":"10.1016\/j.xkme.2020.01.006_bib21","doi-asserted-by":"crossref","first-page":"e512","DOI":"10.3399\/bjgp18X697973","article-title":"Chronic kidney disease and cause-specific hospitalisation: a matched cohort study using primary and secondary care patient data","volume":"68","author":"Iwagami","year":"2018","journal-title":"Br J Gen Pract"},{"issue":"12","key":"10.1016\/j.xkme.2020.01.006_bib22","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1086\/424516","article-title":"Burden of infection in patients with end-stage renal disease requiring long-term dialysis","volume":"39","author":"Berman","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1016\/j.xkme.2020.01.006_bib23","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.5588\/ijtld.15.0081","article-title":"Risk of active tuberculosis in chronic kidney disease: a systematic review and meta-analysis","volume":"19","author":"Al-Efraij","year":"2015","journal-title":"Int J Tuberc Lung Dis"},{"issue":"10","key":"10.1016\/j.xkme.2020.01.006_bib24","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1017\/S0950268810002657","article-title":"Hospitalization in two waves of pandemic influenza A(H1N1) in England","volume":"139","author":"Campbell","year":"2011","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.xkme.2020.01.006_bib25","series-title":"Iron Physiology and Pathophysiology in Humans","first-page":"27","article-title":"Cellular iron physiology","author":"Muckenthaler","year":"2012"},{"issue":"5","key":"10.1016\/j.xkme.2020.01.006_bib26","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.chom.2013.04.010","article-title":"Iron in infection and immunity","volume":"13","author":"Cassat","year":"2013","journal-title":"Cell Host Microbe"},{"issue":"6108","key":"10.1016\/j.xkme.2020.01.006_bib27","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1126\/science.1224577","article-title":"Hepcidin and the iron-infection axis","volume":"338","author":"Drakesmith","year":"2012","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.xkme.2020.01.006_bib28","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s12185-017-2366-2","article-title":"Iron and infection","volume":"107","author":"Ganz","year":"2018","journal-title":"Int J Hematol"},{"issue":"11","key":"10.1016\/j.xkme.2020.01.006_bib29","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.15252\/embr.201540558","article-title":"The iron age of host-microbe interactions","volume":"16","author":"Soares","year":"2015","journal-title":"EMBO Rep"},{"key":"10.1016\/j.xkme.2020.01.006_bib30","doi-asserted-by":"crossref","DOI":"10.1182\/asheducation-2006.1.29","article-title":"Hepcidin and its role in regulating systemic iron metabolism","author":"Ganz","year":"2006","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"7","key":"10.1016\/j.xkme.2020.01.006_bib31","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/nrmicro1930","article-title":"Viral infection and iron metabolism","volume":"6","author":"Drakesmith","year":"2008","journal-title":"Nat Rev Microbiol"},{"issue":"1","key":"10.1016\/j.xkme.2020.01.006_bib32","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1172\/JCI101691","article-title":"The anemia of infection. II. The experimental production of hypoferremia and anemia in dogs","volume":"25","author":"Cartwright","year":"1946","journal-title":"J\u00a0Clin Invest"},{"issue":"4","key":"10.1016\/j.xkme.2020.01.006_bib33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0061050","article-title":"Role of hepcidin in the setting of hypoferremia during acute inflammation","volume":"8","author":"Deschemin","year":"2013","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.xkme.2020.01.006_bib34","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.beha.2004.09.001","article-title":"Modification of iron regulation by the inflammatory response","volume":"18","author":"Weiss","year":"2005","journal-title":"Best Pract Res Clin Haematol"},{"issue":"4","key":"10.1016\/j.xkme.2020.01.006_bib35","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.2353\/ajpath.2008.061145","article-title":"Stimulus-dependent impairment of the neutrophil oxidative burst response in lactoferrin-deficient mice","volume":"172","author":"Ward","year":"2008","journal-title":"Am J Pathol"},{"issue":"3","key":"10.1016\/j.xkme.2020.01.006_bib36","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1189\/jlb.1107781","article-title":"The iron export\u00a0protein ferroportin 1 is differentially expressed in mouse\u00a0macrophage populations and is present in the mycobacterial-containing phagosome","volume":"84","author":"Van Zandt","year":"2008","journal-title":"J\u00a0Leukoc Biol"},{"issue":"51","key":"10.1016\/j.xkme.2020.01.006_bib37","doi-asserted-by":"crossref","first-page":"49727","DOI":"10.1074\/jbc.M209768200","article-title":"Intraphagosomal Mycobacterium tuberculosis acquires iron from both extracellular transferrin and intracellular iron pools. Impact of interferon-gamma and hemochromatosis","volume":"277","author":"Olakanmi","year":"2002","journal-title":"J\u00a0Biol Chem"},{"issue":"6","key":"10.1016\/j.xkme.2020.01.006_bib38","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1089\/ars.2013.5447","article-title":"Are reactive oxygen species always detrimental to pathogens?","volume":"20","author":"Paiva","year":"2014","journal-title":"Antioxid Redox Signal"},{"issue":"6","key":"10.1016\/j.xkme.2020.01.006_bib39","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.ijid.2007.04.007","article-title":"Association of hemochromatosis with infectious diseases: expanding spectrum","volume":"11","author":"Khan","year":"2007","journal-title":"Int J Infect Dis"},{"issue":"3","key":"10.1016\/j.xkme.2020.01.006_bib40","doi-asserted-by":"crossref","first-page":"346","DOI":"10.3201\/eid0503.990305","article-title":"Iron loading and disease surveillance","volume":"5","author":"Weinberg","year":"1999","journal-title":"Emerg Infect Dis"},{"issue":"suppl 1","key":"10.1016\/j.xkme.2020.01.006_bib41","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1089\/sur.2005.6.s1-41","article-title":"Iron and the risk of infection","volume":"6","author":"Pieracci","year":"2005","journal-title":"Surg Infect (Larchmt)"},{"issue":"2","key":"10.1016\/j.xkme.2020.01.006_bib42","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1086\/322017","article-title":"Strain-specific iron-dependent virulence in Escherichia coli","volume":"184","author":"Telang","year":"2001","journal-title":"J\u00a0Infect Dis"},{"issue":"6","key":"10.1016\/j.xkme.2020.01.006_bib43","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.92002","article-title":"Hepcidin-mediated iron sequestration protects against bacterial dissemination during pneumonia","volume":"2","author":"Michels","year":"2017","journal-title":"JCI Insight"},{"issue":"3","key":"10.1016\/j.xkme.2020.01.006_bib44","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1182\/blood-2017-03-772715","article-title":"Endogenous hepcidin and its agonist mediate resistance to selected infections by clearing non-transferrin-bound iron","volume":"130","author":"Stefanova","year":"2017","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.xkme.2020.01.006_bib45","doi-asserted-by":"crossref","first-page":"e00253","DOI":"10.1128\/IAI.00253-18","article-title":"Hepcidin protects against lethal Escherichia coli sepsis in mice inoculated with isolates from septic patients","volume":"86","author":"Stefanova","year":"2018","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.xkme.2020.01.006_bib46","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.chom.2014.12.001","article-title":"Hepcidin-induced hypoferremia is a critical host defense mechanism against the siderophilic bacterium Vibrio vulnificus","volume":"17","author":"Arezes","year":"2015","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.xkme.2020.01.006_bib47","doi-asserted-by":"crossref","first-page":"16670","DOI":"10.1038\/srep16670","article-title":"Oral iron acutely elevates bacterial growth in human serum","volume":"5","author":"Cross","year":"2015","journal-title":"Sci Rep"},{"issue":"11","key":"10.1016\/j.xkme.2020.01.006_bib48","doi-asserted-by":"crossref","first-page":"4527","DOI":"10.1182\/blood-2004-09-3468","article-title":"Redox active plasma iron in C282Y\/C282Y hemochromatosis","volume":"105","author":"Le Lan","year":"2005","journal-title":"Blood"},{"issue":"25","key":"10.1016\/j.xkme.2020.01.006_bib49","doi-asserted-by":"crossref","first-page":"6675","DOI":"10.1182\/blood-2011-08-371849","article-title":"Transfusion of human volunteers with older, stored red blood cells produces extravascular hemolysis and circulating non-transferrin-bound iron","volume":"118","author":"Hod","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.xkme.2020.01.006_bib50","article-title":"Infections associated with iron administration","volume":"19","author":"Nairz","year":"2019","journal-title":"Met Ions Life Sci"},{"issue":"58","key":"10.1016\/j.xkme.2020.01.006_bib51","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1159\/000419357","article-title":"Iron and lymphocytes: reciprocal regulatory interactions","author":"de Sousa","year":"1991","journal-title":"Curr Stud Hematol Blood Transfus"},{"issue":"1","key":"10.1016\/j.xkme.2020.01.006_bib52","first-page":"1","article-title":"Immune cell functions in iron overload","volume":"75","author":"de Sousa","year":"1989","journal-title":"Clin Exp Immunol"},{"issue":"9","key":"10.1016\/j.xkme.2020.01.006_bib53","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1172\/JCI9635","article-title":"Genes that modify the hemochromatosis phenotype in mice","volume":"105","author":"Levy","year":"2000","journal-title":"J\u00a0Clin Invest"},{"issue":"4","key":"10.1016\/j.xkme.2020.01.006_bib54","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1365-2613.2006.00491.x","article-title":"Comparative study between Hfe-\/- and beta2m-\/- mice: progression with age of iron status and liver pathology","volume":"87","author":"Rodrigues","year":"2006","journal-title":"Int J Exp Pathol"},{"issue":"1","key":"10.1016\/j.xkme.2020.01.006_bib55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0008-8749(89)90001-4","article-title":"Collagen arthritis in the rat is initiated by CD4+ T cells and can be amplified by iron","volume":"121","author":"Breedveld","year":"1989","journal-title":"Cell Immunol"},{"issue":"4","key":"10.1016\/j.xkme.2020.01.006_bib56","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1111\/j.1365-2141.1985.tb07367.x","article-title":"Disproportionate lymphoid cell subsets in thalassaemia major: the relative contributions of transfusion and splenectomy","volume":"59","author":"Grady","year":"1985","journal-title":"Br J Haematol"},{"issue":"5","key":"10.1016\/j.xkme.2020.01.006_bib57","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1002\/JLB.3A0318-108R","article-title":"Iron alters\u00a0macrophage polarization status and leads to steatohepatitis and fibrogenesis","volume":"105","author":"Handa","year":"2019","journal-title":"J\u00a0Leukoc Biol"},{"issue":"2","key":"10.1016\/j.xkme.2020.01.006_bib58","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1046\/j.1523-1755.2003.00125.x","article-title":"High-dose parenteral iron sucrose depresses neutrophil intracellular killing capacity","volume":"64","author":"Deicher","year":"2003","journal-title":"Kidney Int"},{"issue":"4","key":"10.1016\/j.xkme.2020.01.006_bib59","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1681\/ASN.V94655","article-title":"Neutrophil impairment associated with iron therapy in hemodialysis patients with functional iron deficiency","volume":"9","author":"Patruta","year":"1998","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"47","key":"10.1016\/j.xkme.2020.01.006_bib60","doi-asserted-by":"crossref","first-page":"e5395","DOI":"10.1097\/MD.0000000000005395","article-title":"Impact of iron deficiency anemia on the function of the immune system in children","volume":"95","author":"Hassan","year":"2016","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"10.1016\/j.xkme.2020.01.006_bib61","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s12887-018-0990-5","article-title":"Assessment of peripheral blood lymphocyte subsets in children with iron deficiency anemia","volume":"18","author":"Aly","year":"2018","journal-title":"BMC Pediatr"},{"issue":"6","key":"10.1016\/j.xkme.2020.01.006_bib62","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1111\/j.1523-1755.2004.00742.x","article-title":"Parenteral iron therapy exacerbates experimental sepsis","volume":"65","author":"Zager","year":"2004","journal-title":"Kidney Int"},{"issue":"2","key":"10.1016\/j.xkme.2020.01.006_bib63","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.gene.2015.10.009","article-title":"HFE gene: structure, function, mutations, and associated iron abnormalities","volume":"574","author":"Barton","year":"2015","journal-title":"Gene"},{"issue":"23","key":"10.1016\/j.xkme.2020.01.006_bib64","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1056\/NEJMra031573","article-title":"Hereditary hemochromatosis\u2014a new look at an old disease","volume":"350","author":"Pietrangelo","year":"2004","journal-title":"N\u00a0Engl J Med"},{"issue":"26","key":"10.1016\/j.xkme.2020.01.006_bib65","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1056\/NEJMc1010939","article-title":"Investigation of a researcher's death due to septicemic plague","volume":"364","author":"Frank","year":"2011","journal-title":"N\u00a0Engl J Med"},{"issue":"11","key":"10.1016\/j.xkme.2020.01.006_bib66","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0079990","article-title":"Effects of highly conserved major histocompatibility complex (MHC) extended haplotypes on iron and low CD8+ T lymphocyte phenotypes in HFE C282Y homozygous hemochromatosis patients from three geographically distant areas","volume":"8","author":"Costa","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.xkme.2020.01.006_bib67","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.bcmd.2006.04.004","article-title":"The CD8+ T-lymphocyte profile as a modifier of iron overload in HFE hemochromatosis: an update of clinical and immunological data from 70 C282Y homozygous subjects","volume":"37","author":"Cruz","year":"2006","journal-title":"Blood Cells Mol Dis"},{"issue":"3","key":"10.1016\/j.xkme.2020.01.006_bib68","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1365-2249.2009.04066.x","article-title":"Low numbers of CD8+ T lymphocytes in hereditary haemochromatosis are explained by a decrease of the most mature CD8+ effector memory T cells","volume":"159","author":"Macedo","year":"2010","journal-title":"Clin Exp Immunol"},{"issue":"10045","key":"10.1016\/j.xkme.2020.01.006_bib69","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/S0140-6736(15)01315-X","volume":"388","author":"Powell","year":"2016","journal-title":"Haemochromatosis. Lancet."},{"issue":"4","key":"10.1016\/j.xkme.2020.01.006_bib70","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.hoc.2014.04.003","article-title":"The pathophysiology of transfusional iron overload","volume":"28","author":"Porter","year":"2014","journal-title":"Hematol Oncol Clin North Am"},{"issue":"1","key":"10.1016\/j.xkme.2020.01.006_bib71","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/bjh.13374","article-title":"Estimating tissue iron burden: current status and future prospects","volume":"170","author":"Wood","year":"2015","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.xkme.2020.01.006_bib72","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.bcmd.2003.08.003","article-title":"The ferroportin disease","volume":"32","author":"Pietrangelo","year":"2004","journal-title":"Blood Cells Mol Dis"},{"issue":"4","key":"10.1016\/j.xkme.2020.01.006_bib73","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1002\/hep.21886","article-title":"Hemochromatosis: an endocrine liver disease","volume":"46","author":"Pietrangelo","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.xkme.2020.01.006_bib74","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.12659\/MSM.896494","article-title":"The role of iron and iron overload\u00a0in chronic liver disease","volume":"22","author":"Milic","year":"2016","journal-title":"Med Sci Monit"},{"issue":"12","key":"10.1016\/j.xkme.2020.01.006_bib75","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.3324\/haematol.2017.170720","article-title":"Ferroportin disease: pathogenesis, diagnosis and treatment","volume":"102","author":"Pietrangelo","year":"2017","journal-title":"Haematologica"},{"key":"10.1016\/j.xkme.2020.01.006_bib76","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.cca.2012.11.013","article-title":"Effect of ferroportin polymorphism on iron homeostasis and infection","volume":"416","author":"Kasvosve","year":"2013","journal-title":"Clin Chim Acta"},{"issue":"5","key":"10.1016\/j.xkme.2020.01.006_bib77","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1053\/j.gastro.2011.01.053","article-title":"Iron levels in hepatocytes and portal tract cells predict progression and outcomes of patients with advanced chronic hepatitis C","volume":"140","author":"Lambrecht","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.xkme.2020.01.006_bib78","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.jcrc.2018.11.005","article-title":"Safety and efficacy of iron therapy on reducing red blood cell transfusion requirements and treating anaemia in critically ill adults: a systematic review with meta-analysis and trial sequential analysis","volume":"49","author":"Shah","year":"2019","journal-title":"J\u00a0Crit Care"},{"issue":"5","key":"10.1016\/j.xkme.2020.01.006_bib79","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0215427","article-title":"Efficacy of perioperative intravenous iron therapy for transfusion in orthopedic surgery: a systematic review and meta-analysis","volume":"14","author":"Shin","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.xkme.2020.01.006_bib80","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s13741-018-0109-4","article-title":"What is the effect of perioperative intravenous iron therapy in patients undergoing non-elective surgery? A systematic review with meta-analysis and trial sequential analysis","volume":"7","author":"Shah","year":"2018","journal-title":"Perioper Med (Lond)"},{"key":"10.1016\/j.xkme.2020.01.006_bib81","doi-asserted-by":"crossref","first-page":"f4822","DOI":"10.1136\/bmj.f4822","article-title":"Safety and efficacy of intravenous iron therapy in reducing requirement for allogeneic blood transfusion: systematic review and meta-analysis of randomised clinical trials","volume":"347","author":"Litton","year":"2013","journal-title":"BMJ"},{"issue":"10","key":"10.1016\/j.xkme.2020.01.006_bib82","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1007\/s10096-013-1877-x","article-title":"Iron deficiency and susceptibility to infections: evaluation of the clinical evidence","volume":"32","author":"Tansarli","year":"2013","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"8","key":"10.1016\/j.xkme.2020.01.006_bib83","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1007\/s00134-018-5320-8","article-title":"Association of iron status with the risk of bloodstream infections: results from the prospective population-based HUNT study in Norway","volume":"44","author":"Mohus","year":"2018","journal-title":"Intensive Care Med"},{"issue":"4","key":"10.1016\/j.xkme.2020.01.006_bib84","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1097\/AOG.0b013e31826af61a","article-title":"False alarms and pseudo-epidemics: the limitations of observational epidemiology","volume":"120","author":"Grimes","year":"2012","journal-title":"Obstet Gynecol"},{"issue":"10168","key":"10.1016\/j.xkme.2020.01.006_bib85","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S0140-6736(18)32840-X","article-title":"Real-world studies no substitute for RCTs in establishing efficacy","volume":"393","author":"Gerstein","year":"2019","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.xkme.2020.01.006_bib86","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1177\/089686080102100310","article-title":"Experience with a large dose (500 mg) of intravenous iron dextran and iron saccharate in peritoneal dialysis patients","volume":"21","author":"Prakash","year":"2001","journal-title":"Perit Dial Int"},{"issue":"1","key":"10.1016\/j.xkme.2020.01.006_bib87","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/sdi.12168","article-title":"Iron and infection in hemodialysis patients","volume":"27","author":"Ishida","year":"2014","journal-title":"Semin Dial"},{"issue":"1","key":"10.1016\/j.xkme.2020.01.006_bib88","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/ki.2014.275","article-title":"Data from the Dialysis Outcomes and Practice Patterns Study validate an association between high intravenous iron doses and mortality","volume":"87","author":"Bailie","year":"2015","journal-title":"Kidney Int"},{"issue":"4","key":"10.1016\/j.xkme.2020.01.006_bib89","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1093\/ndt\/gfu349","article-title":"Effect of intravenous iron use on hospitalizations in patients undergoing hemodialysis: a comparative effectiveness analysis from the DEcIDE-ESRD study","volume":"30","author":"Tangri","year":"2015","journal-title":"Nephrol Dial Transplant"},{"issue":"12","key":"10.1016\/j.xkme.2020.01.006_bib90","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0114144","article-title":"Iron supplementation and mortality in incident dialysis patients: an observational study","volume":"9","author":"Zitt","year":"2014","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.xkme.2020.01.006_bib91","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/ki.2014.114","article-title":"Association between hemoglobin variability, serum ferritin levels, and adverse events\/mortality in maintenance hemodialysis patients","volume":"86","author":"Kuragano","year":"2014","journal-title":"Kidney Int"},{"issue":"10","key":"10.1016\/j.xkme.2020.01.006_bib92","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.2215\/CJN.01090115","article-title":"Receipt of intravenous iron and clinical outcomes among hemodialysis patients hospitalized for infection","volume":"10","author":"Ishida","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"10.1016\/j.xkme.2020.01.006_bib93","doi-asserted-by":"crossref","first-page":"457","DOI":"10.2215\/CJN.05390517","article-title":"Safety of intravenous iron in dialysis: a systematic review and meta-analysis","volume":"13","author":"Hougen","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"10.1016\/j.xkme.2020.01.006_bib94","doi-asserted-by":"crossref","first-page":"728","DOI":"10.2215\/CJN.03970318","article-title":"Safety of dynamic intravenous iron administration strategies in hemodialysis patients","volume":"14","author":"Li","year":"2019","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"10.1016\/j.xkme.2020.01.006_bib95","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1056\/NEJMoa1810742","article-title":"Intravenous iron in patients undergoing maintenance hemodialysis","volume":"380","author":"Macdougall","year":"2019","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.xkme.2020.01.006_bib96","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1186\/s12882-019-1495-7","article-title":"Intravenous iron supplementation does not increase infectious disease risk in hemodialysis patients: a nationwide cohort-based case-crossover study","volume":"20","author":"Yen","year":"2019","journal-title":"BMC Nephrol"},{"issue":"7","key":"10.1016\/j.xkme.2020.01.006_bib97","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1681\/ASN.2012121164","article-title":"Infection risk with bolus versus maintenance iron supplementation in hemodialysis patients","volume":"24","author":"Brookhart","year":"2013","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"6","key":"10.1016\/j.xkme.2020.01.006_bib98","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1053\/j.ajkd.2016.10.031","article-title":"Safety of intravenous iron in hemodialysis: longer-term comparisons of iron sucrose versus sodium ferric gluconate complex","volume":"69","author":"Winkelmayer","year":"2017","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10.1016\/j.xkme.2020.01.006_bib99","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1053\/j.ajkd.2015.07.026","article-title":"Comparative short-term safety of sodium ferric gluconate versus iron sucrose in hemodialysis patients","volume":"67","author":"Brookhart","year":"2016","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"10.1016\/j.xkme.2020.01.006_bib100","doi-asserted-by":"crossref","first-page":"348","DOI":"10.5414\/CNP66348","article-title":"Association of different intravenous iron preparations with risk of bacteremia in maintenance hemodialysis patients","volume":"66","author":"Sirken","year":"2006","journal-title":"Clin Nephrol"},{"issue":"5","key":"10.1016\/j.xkme.2020.01.006_bib101","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1053\/j.ajkd.2008.05.033","article-title":"Intravenous versus oral iron supplementation for the treatment of anemia in CKD: systematic review and meta-analysis","volume":"52","author":"Rozen-Zvi","year":"2008","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"10.1016\/j.xkme.2020.01.006_bib102","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1093\/ndt\/gfq613","article-title":"A\u00a0randomized controlled trial comparing intravenous ferric carboxymaltose with oral iron for treatment of iron deficiency anaemia of non-dialysis-dependent chronic kidney disease patients","volume":"26","author":"Qunibi","year":"2011","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"10.1016\/j.xkme.2020.01.006_bib103","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1038\/ki.2015.163","article-title":"A\u00a0randomized trial of intravenous and oral iron in chronic kidney disease","volume":"88","author":"Agarwal","year":"2015","journal-title":"Kidney Int"},{"issue":"11","key":"10.1016\/j.xkme.2020.01.006_bib104","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1093\/ndt\/gfu201","article-title":"FIND-CKD: a randomized trial of intravenous ferric carboxymaltose versus oral iron in patients with chronic kidney disease and iron deficiency anaemia","volume":"29","author":"Macdougall","year":"2014","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"10.1016\/j.xkme.2020.01.006_bib105","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1053\/j.ajkd.2016.04.018","article-title":"Intravenous versus oral iron supplementation for the treatment of anemia in CKD: an updated systematic review and meta-analysis","volume":"68","author":"Shepshelovich","year":"2016","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"10.1016\/j.xkme.2020.01.006_bib106","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1681\/ASN.2014020212","article-title":"Ferric citrate controls phosphorus and delivers iron in patients on dialysis","volume":"26","author":"Lewis","year":"2015","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"3","key":"10.1016\/j.xkme.2020.01.006_bib107","first-page":"249","article-title":"The iron tug-of-war between bacterial siderophores and innate immunity","volume":"11","author":"Golonka","year":"2019","journal-title":"J\u00a0Innate Immun"},{"issue":"2","key":"10.1016\/j.xkme.2020.01.006_bib108","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1159\/000493684","article-title":"The effect of recombinant human erythropoietin on bacterial growth: a dual-edged sword","volume":"5","author":"Mittal","year":"2019","journal-title":"Kidney Dis (Basel)"},{"issue":"3","key":"10.1016\/j.xkme.2020.01.006_bib109","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1681\/ASN.2006091034","article-title":"Ferric gluconate is highly efficacious in anemic hemodialysis patients with high serum ferritin and low transferrin saturation: results of the Dialysis Patients' Response to IV Iron with Elevated Ferritin (DRIVE) Study","volume":"18","author":"Coyne","year":"2007","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"4","key":"10.1016\/j.xkme.2020.01.006_bib110","first-page":"279","article-title":"KDIGO clinical practice guideline for anemia in chronic kidney disease","volume":"2","year":"2012","journal-title":"Kidney Int Suppl"},{"issue":"4","key":"10.1016\/j.xkme.2020.01.006_bib111","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.kint.2018.06.011","article-title":"Executive summary of the 2018 KDIGO Hepatitis C in CKD Guideline: welcoming advances in evaluation and management","volume":"94","author":"Jadoul","year":"2018","journal-title":"Kidney Int"},{"issue":"6","key":"10.1016\/j.xkme.2020.01.006_bib112","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1093\/ckj\/sfw104","article-title":"HIV and kidney diseases: 35 years of history and consequences","volume":"9","author":"Campos","year":"2016","journal-title":"Clin Kidney J"}],"container-title":["Kidney Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590059520300467?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590059520300467?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T01:21:04Z","timestamp":1762910464000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590059520300467"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":111,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["S2590059520300467"],"URL":"https:\/\/doi.org\/10.1016\/j.xkme.2020.01.006","relation":{},"ISSN":["2590-0595"],"issn-type":[{"value":"2590-0595","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Iron Administration, Infection, and Anemia Management in CKD: Untangling the Effects of Intravenous Iron Therapy on Immunity and Infection Risk","name":"articletitle","label":"Article Title"},{"value":"Kidney Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xkme.2020.01.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Inc. on behalf of the National Kidney Foundation, Inc.","name":"copyright","label":"Copyright"}]}}